|
10 Companies |
|
15 Products |
|
15 Products |
|
32 Mechanisms of Action |
|
1 Trial |
|
231 News |
|
| «12345» |
- prednisone / Generic mfg.
Trial termination: EPITOME: Efficacy of Prednisone In the Treatment of Ocular Myasthenia (clinicaltrials.gov) - Oct 30, 2013
P3, N=11, Terminated, Sponsor: Michael Benatar
Active, not recruiting --> Terminated; Slow recruitment rate
- Enrollment change: Investigation of the Role of FHL-1 and Myostatin in Intensive Care Unit Acquired Paresis (ICUAP) (clinicaltrials.gov) - Oct 15, 2013
P=N/A, N=13, Completed, Sponsor: Imperial College London
Active, not recruiting --> Terminated; Slow recruitment rate N=42 --> 13
- Trial completion: Investigation of the Role of FHL-1 and Myostatin in Intensive Care Unit Acquired Paresis (ICUAP) (clinicaltrials.gov) - Oct 15, 2013
P=N/A, N=13, Completed, Sponsor: Imperial College London
N=42 --> 13 Recruiting --> Completed
- fluoxetine / Generic mfg.
New P2 trial: RCT of a Neuroplasticity Agent and CI Therapy for Severe Arm Paresis After Stroke (clinicaltrials.gov) - Oct 14, 2013
P2, N=40, Not yet recruiting, Sponsor: University of Alabama at Birmingham
- || Bridion (sugammadex) / Merck (MSD)
New P3 trial: SUDIA: Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex (clinicaltrials.gov) - Oct 10, 2013
P3, N=75, Recruiting, Sponsor: University Hospital, Antwerp
- | Bridion (sugammadex) / Merck (MSD)
Enrollment open: SUDIA: Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex (clinicaltrials.gov) - Oct 10, 2013
P3, N=75, Recruiting, Sponsor: University Hospital, Antwerp
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: Influence of Physical Therapy for Foot and Ankle in the Gait of Individuals With Diabetic Neuropathy (clinicaltrials.gov) - Sep 9, 2013
P1, N=55, Completed, Sponsor: University of Sao Paulo General Hospital
Not yet recruiting --> Recruiting N=40 --> 55
- Trial completion: Influence of Physical Therapy for Foot and Ankle in the Gait of Individuals With Diabetic Neuropathy (clinicaltrials.gov) - Sep 9, 2013
P1, N=55, Completed, Sponsor: University of Sao Paulo General Hospital
N=40 --> 55 Active, not recruiting --> Completed
- Enrollment open: DORIAN: Developmental ORIgins of Healthy and Unhealthy AgeiNg: the Role of Maternal Obesity (clinicaltrials.gov) - Aug 25, 2013
P=N/A, N=55, Recruiting, Sponsor: Turku University Hospital
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change, HEOR: Oxi-Stress: Oxidative Stress and Nutritional Supplementation Intervention Study (clinicaltrials.gov) - Jul 29, 2013
P2, N=21, Completed, Sponsor: University of Saskatchewan
Not yet recruiting --> Recruiting N=154 --> 21
- Trial completion, HEOR: Oxi-Stress: Oxidative Stress and Nutritional Supplementation Intervention Study (clinicaltrials.gov) - Jul 29, 2013
P2, N=21, Completed, Sponsor: University of Saskatchewan
N=154 --> 21 Recruiting --> Completed
- Enrollment change: Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms (clinicaltrials.gov) - Jul 24, 2013
P2/3, N=50, Active, not recruiting, Sponsor: Catherine Buettner
Recruiting --> Completed N=100 --> 50
- Enrollment closed: Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms (clinicaltrials.gov) - Jul 24, 2013
P2/3, N=50, Active, not recruiting, Sponsor: Catherine Buettner
N=100 --> 50 Recruiting --> Active, not recruiting
- Enrollment open: The Impact of Early Mobilization Protocol in Patients in the ICU (clinicaltrials.gov) - Jul 10, 2013
P=N/A, N=33, Recruiting, Sponsor: Universidade Federal de Santa Maria
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Mayzent (siponimod) / Novartis
Trial termination: Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis (clinicaltrials.gov) - Jun 13, 2013
P2, N=29, Terminated, Sponsor: Novartis Pharmaceuticals
Not yet recruiting --> Recruiting Completed --> Terminated; Trial was prematurely terminated due to enrollment challenges.
- ropivacaine / Generic mfg.
Trial completion, Surgery: Initial Local Anesthetic Dose With Continuous Interscalene Analgesia (clinicaltrials.gov) - May 21, 2013
P=N/A, N=36, Completed, Sponsor: William Beaumont Hospitals
Completed --> Terminated; Trial was prematurely terminated due to enrollment challenges. Active, not recruiting --> Completed
- | New P2 trial: Once-Daily Oral Dose of BeneFlax to Healthy Older Adults (clinicaltrials.gov) - May 1, 2013
P2, N=60, Recruiting, Sponsor: University of Saskatchewan
- | Trial completion: Functional Recovery in Stroke Patients With Task-Specific Robot-Aided Arm Therapy (clinicaltrials.gov) - Apr 18, 2013
P2/3, N=76, Completed, Sponsor: University of Zurich
Active, not recruiting --> Completed Active, not recruiting --> Completed
- New P4 trial: FacialReinn: Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty (clinicaltrials.gov) - Apr 14, 2013
P4, N=15, Recruiting, Sponsor: University Hospital, Caen
- Mayzent (siponimod) / Novartis
Enrollment change: Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis (clinicaltrials.gov) - Feb 12, 2013
P2, N=29, Terminated, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Completed N=40 --> 29
- dexamethasone injection / Generic mfg.
Trial initiation date: Comparing Subsartorial Saphenous Nerve Blocks With and Without Dexamethasone for Anterior Cruciate Ligament Reconstruction (clinicaltrials.gov) - Feb 6, 2013
P4, N=195, Recruiting, Sponsor: Hospital for Special Surgery, New York
N=40 --> 29 Initiation date: Apr 2012 --> Jul 2012
- dexamethasone injection / Generic mfg.
Enrollment open: Comparing Subsartorial Saphenous Nerve Blocks With and Without Dexamethasone for Anterior Cruciate Ligament Reconstruction (clinicaltrials.gov) - Feb 6, 2013
P4, N=195, Recruiting, Sponsor: Hospital for Special Surgery, New York
Initiation date: Apr 2012 --> Jul 2012 Not yet recruiting --> Recruiting
- Enrollment closed: ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit (clinicaltrials.gov) - Feb 4, 2013
P1, N=90, Active, not recruiting, Sponsor: Vanderbilt University
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Enrollment open: Multimodal Exercises to Improve Leg Function After Spinal Cord Injury (clinicaltrials.gov) - Jan 22, 2013
P=N/A, N=75, Recruiting, Sponsor: Department of Veterans Affairs
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Enrollment change: Characteristics of Andersen-Tawil Syndrome (clinicaltrials.gov) - Jan 14, 2013
P=N/A, N=28, Completed, Sponsor: University of Rochester
Not yet recruiting --> Recruiting N=50 --> 28
- Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
Trial completion: A Pilot Trial of Rituxan in Refractory Myasthenia Gravis (clinicaltrials.gov) - Jan 14, 2013
P1/2, N=10, Completed, Sponsor: University of Vermont
N=50 --> 28 Active, not recruiting --> Completed
- Trial completion: Characteristics of Andersen-Tawil Syndrome (clinicaltrials.gov) - Jan 14, 2013
P=N/A, N=28, Completed, Sponsor: University of Rochester
Active, not recruiting --> Completed Recruiting --> Completed
- Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
Trial completion: FORCE: Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis (clinicaltrials.gov) - Dec 9, 2012
P2, N=30, Completed, Sponsor: Assistance Publique - H
Recruiting --> Completed Recruiting --> Completed
- Clinical: Influence of Respiratory Muscle Training in Elderly Hypertensive Women With Respiratory Muscle Weakness (clinicaltrials.gov) - Dec 4, 2012
P=N/A, N=4, Completed, Sponsor: Universidade Federal do Rio Grande do Norte
- | prednisone / Generic mfg.
Enrollment closed: Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy (clinicaltrials.gov) - Dec 3, 2012
P3, N=150, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment closed: Efficacy of Methotrexate in Myasthenia Gravis (clinicaltrials.gov) - Nov 20, 2012
P2, N=50, Active, not recruiting, Sponsor: University of Kansas
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Clinical: SR-WBV Training for Frail Elderly in the Skilling up Stage (clinicaltrials.gov) - Oct 10, 2012
P=N/A, N=40, Recruiting, Sponsor: Bern University of Applied Sciences
- Clinical: MOBIL: Vibrational-proprioceptive Resistance Exercise Training Versus Neuromuscular Electrical Stimulation Training in Elderly People With Muscle Weakness (clinicaltrials.gov) - Sep 4, 2012
P=N/A, N=150, Recruiting, Sponsor: Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation
- Clinical: DesCoM-1: Involvement of Nervous System in Muscle Weakness in COPD Patients (clinicaltrials.gov) - Sep 4, 2012
P=N/A, N=45, Recruiting, Sponsor: Groupe Fontalvie
- New P4 trial: Ultrasound Guided Adductor Canal Block Versus Femoral Nerve Block for Quadriceps Strength and Fall-risk (clinicaltrials.gov) - Jul 30, 2012
P4, N=16, Completed, Sponsor: St. Luke's-Roosevelt Hospital Center
- Clinical: UROHTLV: Urological Physical Therapy in HTLV-1 With Urinary Symptoms (clinicaltrials.gov) - Jul 25, 2012
P=N/A, N=20, Enrolling by invitation, Sponsor: Hospital Universitário Professor Edgard Santos
- Clinical: Respiratory Muscle Training in Institutionalized Elderly Population (clinicaltrials.gov) - Jun 18, 2012
P=N/A, N=71, Completed, Sponsor: University of Valencia
- | New P2 trial, Patient reported outcomes: COMPALA: Comparing the Clinical Effects of Posterior Approach Versus Lateral Approach in Osteoarthritis Patients With a THA (clinicaltrials.gov) - Jun 10, 2012
P2, N=80, Recruiting, Sponsor: Odense University Hospital
- Clinical: INCA: Inspiratory Muscle Training in Patients With Chronic Heart Failure (clinicaltrials.gov) - May 23, 2012
P=N/A, N=22, Recruiting, Sponsor: Parc de Salut Mar
- ||||| landogrozumab (LY2495655) / Eli Lilly
New P2 trial: A Study in Older Participants Who Have Fallen and Have Muscle Weakness (clinicaltrials.gov) - May 21, 2012
P2, N=172, Completed, Sponsor: Eli Lilly and Company
- Trial completion: Effects of Therapeutic Music Combined With Loaded Sit-to-Stand Resistance Exercise for Children With Spastic Diplegia (clinicaltrials.gov) - May 15, 2012
P=N/A, N=36, Completed, Sponsor: National Taiwan University Hospital
Recruiting --> Active, not recruiting Recruiting --> Completed
- | dexamethasone injection / Generic mfg.
New P4 trial: Comparing Subsartorial Saphenous Nerve Blocks With and Without Dexamethasone for Anterior Cruciate Ligament Reconstruction (clinicaltrials.gov) - Apr 25, 2012
P4, N=195, Recruiting, Sponsor: Hospital for Special Surgery, New York
- Trial withdrawal: Exercise and Nutritional Intervention for Deconditioned Older Adults (clinicaltrials.gov) - Apr 10, 2012
P=N/A, N=0, Withdrawn, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Active, not recruiting --> Withdrawn
- Enrollment change: Exercise and Nutritional Intervention for Deconditioned Older Adults (clinicaltrials.gov) - Apr 10, 2012
P=N/A, N=0, Withdrawn, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Withdrawn N=48 --> 0
- |||||||||| piracetam / Generic mfg.
New P3 trial: A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome (clinicaltrials.gov) - Mar 6, 2012
P3, N=120, Not yet recruiting, Sponsor: Biolab Sanus Farmaceutica
- Trial termination: Modified Constrained - Induced Movement Therapy Compared to Intensive Bimanual Training (clinicaltrials.gov) - Mar 4, 2012
P=N/A, N=30, Terminated, Sponsor: University of Bergen
N=48 --> 0 Recruiting --> Terminated; Due to recruitment difficulties the trial was stopped after an interim analysis at 30 patients.
- Enrollment change: Modified Constrained - Induced Movement Therapy Compared to Intensive Bimanual Training (clinicaltrials.gov) - Mar 4, 2012
P=N/A, N=30, Terminated, Sponsor: University of Bergen
Recruiting --> Terminated; Due to recruitment difficulties the trial was stopped after an interim analysis at 30 patients. N=60 --> 30
- | Enrollment open: IMTCO: Effects of Inspiratory Muscle Training in COPD (clinicaltrials.gov) - Feb 7, 2012
P3, N=160, Recruiting, Sponsor: Katholieke Universiteit Leuven
N=60 --> 30 Not yet recruiting --> Recruiting
- Trial initiation date: ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit (clinicaltrials.gov) - Jan 8, 2012
P1, N=90, Active, not recruiting, Sponsor: Vanderbilt University
Not yet recruiting --> Recruiting Initiation date: Nov 2010 --> Feb 2011
- Enrollment change: ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit (clinicaltrials.gov) - Jan 8, 2012
P1, N=90, Active, not recruiting, Sponsor: Vanderbilt University
Initiation date: Nov 2010 --> Feb 2011 N=60 --> 90